Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

MergersCorp M&A International

JULY 5, 2024

In 2023 the primary market for global convertibles was more than double since 2022, with volumes reaching USD 78Bn via 115 new issues. The strained relations between the US and China, marked by broad financial sanctions and regulatory scrutiny have made initial public offering and follow on share sales nearly inaccessible for Chinese firms.

Debt 52

Debt Stock Initial Public Offering Capital 52

Cooley M&A

JANUARY 30, 2024

Globally, 229 campaigns launched in 2023, just under 2022 campaign levels, ushering in the most active two-year period on record. [1] 1] Activism in Europe was a core driver of activity, representing 28% of all campaigns and a 30% increase from 2022. [2] 4] Activists won 134 board seats globally in 2023, a 30% increase from 2022.

Private Equity 52

Private Equity M&A Capital Investors 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity. billion, Mirati for $5.8

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 trillion. [2] trillion.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

NOVEMBER 18, 2024

This active M&A market continued for almost three years until mid-to-late 2022 when interest rates increased rapidly, making it much more expensive to buy or build new car wash locations.

Private Equity 52

Private Equity Equities IPO Valuation 52

Cooley M&A

JANUARY 22, 2025

This stands in stark contrast to 2023, when life sciences M&A outperformed the market with a 50% increase in deal value from 2022 compared to a 17% decline in overall M&A activity across all industries. Luckily, theres more to this years story.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64